| Basics |
Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company developing and commercializing pharmaceutical products. The company's products include Bloxiverz, Vazculep, Akovaz, Karbinal ER, AcipHex Sprinkle, Cefaclor and Flexichamber.
|
| IPO Date: |
July 1, 1996 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$927.73M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.23 | 3.08%
|
| Avg Daily Range (30 D): |
$0.24 | 2.88%
|
| Avg Daily Range (90 D): |
$0.20 | 2.41%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.64M |
| Avg Daily Volume (30 D): |
1.12M |
| Avg Daily Volume (90 D): |
1.16M |
| Trade Size |
| Avg Trade Size (Sh.): |
139 |
| Avg Trade Size (Sh.) (30 D): |
79 |
| Avg Trade Size (Sh.) (90 D): |
87 |
| Institutional Trades |
| Total Inst.Trades: |
1,010 |
| Avg Inst. Trade: |
$1.56M |
| Avg Inst. Trade (30 D): |
$1.24M |
| Avg Inst. Trade (90 D): |
$1.31M |
| Avg Inst. Trade Volume: |
.14M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.85M |
| Avg Closing Trade (30 D): |
$1.19M |
| Avg Closing Trade (90 D): |
$1.21M |
| Avg Closing Volume: |
153.44K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q3 2024 |
|
Basic EPS
|
|
$-.05
|
$-.03
|
|
Diluted EPS
|
|
$-.05
|
$-.03
|
|
Revenue
|
$
|
$ 52.51M
|
$ 50.03M
|
|
Gross Profit
|
$
|
$ 46.93M
|
$ 43.87M
|
|
Net Income / Loss
|
$
|
$ -4.92M
|
$ -2.63M
|
|
Operating Income / Loss
|
$
|
$ -3M
|
$ -.33M
|
|
Cost of Revenue
|
$
|
$ 5.58M
|
$ 6.16M
|
|
Net Cash Flow
|
$
|
$ 5M
|
$ -.27M
|
|
PE Ratio
|
|
|
|
|
